Director, Specialty PCS - Obesity & Metabolics

Responsibilities

• Partners with US Specialty commercial leads, Asset Strategy Team (AST) and other key deliverables teams to develop commercialization strategies and provide commercial POV on key asset strategies and decisions with commercial implications, supporting development milestones and governance.
• Drive the development of an initial go-to-market (GTM) strategy within Obesity: Gain and synthesize insights from current obesity space to map current patient transactional journey and unmet needs to potential GTM channels and options
• Partner cross functionally to tap into AbbVie capabilities and expertise to design and develop initial GTM obesity strategy, with consideration to early pilots
• Assessment of prioritized disease areas and execution of Specialty Portfolio Pipeline strategy: Leads the development of prioritized disease area strategies, to identify and define key areas of future potential opportunity.
• Partners with Search and Evaluation and Business Development to pull-through disease area strategies, identifying and exploring aligned opportunities and supporting commercial due diligence activities as appropriate.
• General for Pipeline Commercialization & Strategy
• Partners cross-functionally to build internal and external innovation plan, with consideration to regulatory dynamics, portfolio dynamics, and AbbVie capabilities, to pull-through disease area strategies.
• Partners with BD&A, S&E, and the cross functional team to execute aligned BD strategy, supporting commercial due diligence activities.
• Specific to development of Early Brand Plans: Drives development of early brand plans; crystalizing commercial and strategic insights by synthesizing product, brand, customer, consumer, and competitive information into the development of asset plans
• Leads market analysis, identifies key market value drivers, growth opportunities, target product profiles, product positioning & revenue potential
• Drives prioritization of key leverage points in the treatment process and develops behavioral objectives for each stakeholder group.
• Supports development of scientific platform that drives data generation in order to satisfy global and area requirements for target product label and target product claims.
• Identifies Critical Success Factors and solves for gaps in order to enable successful launch.
• Learns new disease states quickly, ensuring focus on the patient as the North Star, and rapidly acquires HCP and Payer insights to inform unmet needs analysis and future market value drivers.
• Is a conduit between development and commercial teams, fostering information flow that optimizes disease area and asset opportunities.
• Builds strong relationships with internal and external partners, including External Experts like IDs and PCPs that treat COVID, leverages expertise to strengthen the asset value proposition.
• Leads internal processes accurately reflecting disease and asset opportunity and required support (LRP, Annual Plan, etc.).
• Is the commercial voice at

Additional Information

The Specialty Pipeline Commercialization & Strategy (PCS) team leads the development of global commercialization strategies for Specialty assets in AbbVie's pipeline and forward-looking disease area strategies aligned to the portfolio strategy. Additionally, Specialty PCS partners with the on-market Commercial teams to maximize our on-market footprint through follow-on indications and other development initiatives. Key disease areas of focus in the Specialty pipeline include Obesity, Metabolics, Gastroenterology, and other areas of exploration. The focus for this role will include Obesity and Metabolics . As the Director, Specialty PCS - Obesity & Metabolics, this role will lead the development and evolution of the global commercialization strategy for select assets in Specialty's Obesity and Metabolics pipeline. This role will also drive the development of an initial go-to-market strategy within Obesity, partnering cross functionally to tap into AbbVie capabilities and expertise. Finally, this individual will also support the development and evolution of disease area strategies, evaluation of new investment opportunities, and support of commercial due diligence activities as appropriate. The Director, Specialty PCS will report to the Specialty Pipeline Commercialization & Strategy Lead, and will be based in our offices in Lake County, IL.

Your Match

How well this role fits your profile.

Company Intel

What employees say

Worked at Abbvie? Share your experience